CARILLON TOWER ADVISERS, INC. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2020$53,754,000
+520.0%
310,642
+298.8%
0.33%
+181.9%
Q3 2020$8,670,000
-100.0%
77,894
-86.4%
0.12%
-68.0%
Q1 2020$36,949,314,000
-23.4%
572,6800.0%0.36%
+12.4%
Q4 2019$48,259,744,000
+112590.6%
572,6800.0%0.32%
+8.1%
Q3 2019$42,825,000572,6800.30%
Other shareholders
NOVOCURE LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$77,833,00015.51%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Darsana Capital Partners LP 700,000$155,274,0004.42%
MORGAN JESS S & CO INC 23,775$5,274,0003.47%
Soleus Capital Management, L.P. 98,975$21,955,0003.38%
Montanaro Asset Management Ltd 116,650$25,875,0003.26%
Taylor Frigon Capital Management LLC 31,035$6,884,0002.15%
Rhenman & Partners Asset Management AB 120,000$26,618,0001.81%
COURAGE CAPITAL MANAGEMENT LLC 10,000$2,218,0001.33%
Derbend Asset Management 5,789$1,284,0001.20%
View complete list of NOVOCURE LTD shareholders